Currently, out of the existing stock ratings of Dennis Ding - 10 which are a Buy (90.91%), 1 which are a Hold (9.09%)

Dennis Ding

Work Performance Price Targets & Ratings Chart

Analyst Dennis Ding works at JEFFERIES and is covering the Healthcare sector with 25 price targets and ratings displayed on 6 stocks.

Dennis Ding's average stock forecast success ratio is 33.33% with an average time for price targets to be met of 39 days.

Most recent stock forecast was given on PRDS, at 03-Apr-2023.

Wall Street Analyst Dennis Ding

Analyst best performing recommendations are on ROIV.
The best stock recommendation documented was for ROIV at 11/1/2021. The price target of $10 was fulfilled within 38 days with a profit of $2.19 (28.04%) receiving and performance score of 7.38.

Average potential price target upside

  • of $2.23 (28.62%) on ROIV.
ABUS Arbutus Biopharma NGM NGM Biopharmaceuticals PRDS ROIV CINC CORT Corcept Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

6

$4 (200.00%)

6

9 days ago

0/8 (0%)

$3.75 (150.13%)

Buy

6

$4 (200.00%)

6

1 months 17 days ago

2/8 (25%)

$2.1 (80.54%)

18

Buy

6

$4 (200.00%)

6

2 months 15 days ago

0/3 (0%)

$4.35 (169.15%)

Buy

5

$2 (66.67%)

4

1 years 7 months 18 days ago

0/3 (0%)

$1.22 (39.59%)

Buy

7

$5 (250.00%)

8

2 years 2 months 24 days ago

0/5 (0%)

$5.27 (140.17%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Dennis Ding is most bullish on?

Potential upside of $0 has been obtained for PRDS

What Year was the first public recommendation made by Dennis Ding?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart